In this study, the authors first demonstrated that reactive astrocytes in the AD brain (of rodent and post-mortem human) exhibit elevated acetate uptake through increased expression of monocarboxylate transporter 1 (MCT1). The gene discussed is SLC16A1; the disease is Alzheimer disease.